共 50 条
- [41] Keeping Up with Advancing Technology in Next-Generation Sequencing (NGS): Validation of the Illumina MiSeq Platform for Use with a Previously Validated NGS Panel Test JOURNAL OF MOLECULAR DIAGNOSTICS, 2013, 15 (06): : 846 - 846
- [48] Utility Of A Comprehensive Cost-Effective Targeted DNA/RNA Panel (170 Genes) On A Next Generation Sequencing (NGS) Platform In Evaluation Of Melanoma For Tumor Specific Information, Microsatellite Instability (MSI) And Calculating The Overall Tumor Mutation Burden (TMB) MODERN PATHOLOGY, 2018, 31 : 201 - 201
- [49] Utility Of A Comprehensive Cost-Effective Targeted DNA/RNA Panel (170 Genes) On A Next Generation Sequencing (NGS) Platform In Evaluation Of Melanoma For Tumor Specific Information, Microsatellite Instability (MSI) And Calculating The Overall Tumor Mutation Burden (TMB) LABORATORY INVESTIGATION, 2018, 98 : 201 - 201
- [50] Evaluation of Intraoperative Sampling for Genomic Analysis of Central Nervous System (CNS) Tumors by Next-Generation Sequencing (NGS). JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (06): : 1057 - 1057